← All stocks

Tenaya Therapeutics, Inc.

TNYA Net buying
CIK 0001858848 #4093 in the set updated 18 Sep 2026
Bought (120 mo)
$161.69M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$6.39M
$89.00K on a plan · $0.00 straight out of an exercise
Sold at will
$6.30M
72 of 76 sales
Net
+$155.30M
+$155.39M against sales at will

By person

12 insiders · 96 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
GOEDDEL DAVID V
Director
$64.56M (8)
+$64.56M
54,299,129
$38.54M
COLUMN GROUP III GP, LP entity
10% owner
$64.56M (8)
$5.93M (12)
+$58.63M
4,985,570
$3.54M
Casdin Eli
Director
$19.23M (2)
+$19.23M
6,440,829
$4.57M
+1,679%
Casdin Partners Master Fund, L.P. entity
10% owner
$12.75M (1)
+$12.75M
361,969
$256.93K
Srivastava Deepak
Director
$600.00K (1)
+$600.00K
372,435
$264.35K
+162.9%
Hoey Timothy
Chief Scientific Officer
$145.41K (7) scheduled
−$145.41K
245,346
$174.15K
+22.7%
Ali Faraz
Chief Executive Officer
$143.72K (19)
−$143.72K
539,782
$383.14K
Tingley Whittemore
Chief Medical Officer
$107.29K (20)
−$107.29K
263,073
$186.73K
+719.3%
PATTERSON LEONE D
Chief Fin. and Bus. Officer
$47.44K (2)
−$47.44K
95,755
$67.97K
+1,671%
Saito Chihiro
SVP, Accounting and Fin. Ops.
$11.63K (4)
−$11.63K
60,983
$43.29K
+50.2%
Higa Tomohiro
SVP, Finance
$10.89K (12)
−$10.89K
118,267
$83.95K
+15.8%
Kang JeenJoo
Director
25,000
$17.75K
+100.0%

No percentages here. This company's share count has moved by a factor of 2.8 over the window, from 79,220,516 to 224,230,012 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Hoey Timothy
5 Mar 2024
Chief Scientific Officer
Sold on a plan
3,300
$7.00
$23.10K
Hoey Timothy
20 Feb 2024
Chief Scientific Officer
Sold on a plan
200
$6.17
$1.23K
Hoey Timothy
20 Feb 2024
Chief Scientific Officer
Sold on a plan
6,369
$5.31
$33.81K
Hoey Timothy
29 Aug 2023
Chief Scientific Officer
Sold on a plan
7,243
$4.26
$30.86K

What was left out

Form 4 filings counted 124
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 0
Sales at will 72
Transactions with no price 0
Shares from compensation/vesting 25,322,084
Sales filed before the plan box existed 1
History held since 4 Aug 2021